Applications of (1S,4S)-2-Boc-2,5-Diazabicyclo[2.2.1]Heptane in Industrial Manufacturing

As a dedicated producer of (1S,4S)-2-Boc-2,5-diazabicyclo[2.2.1]heptane, we support downstream industries with high-purity supply for advanced synthesis. Our expertise extends to key sectors that rely on this intermediate to build specialized compounds, adhering strictly to compliance and integration requirements laid down by pharmaceutical, agrochemical, and specialty chemical manufacturing standards.

1. Active Pharmaceutical Ingredient (API) Synthesis for CNS Therapeutics

Pharmaceutical companies utilize this bicyclic protected diamine extensively during targeted CNS drug development, particularly for piperidine-based moieties. The compound enters the production pipeline as a crucial building block in stereoselective transformations to construct advanced intermediates that demand absolute configuration integrity. Companies balance Boc-protection stability with controlled deprotection during final steps, directly affecting yield and quality testing against regulatory release specifications for prescription drugs.

Industry compliance standards

• ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients)
• EU GMP Annex 8
• United States Pharmacopeia (USP) General Chapters <60>, <232>
• EDQM CEP requirements

Typical usage ratio

• 5–15 mol% relative to target intermediate; adjusted based on reaction stoichiometry, impurity profile control, and maintaining chiral integrity.

Downstream process integration

• Direct introduction as a chiral amine building block in multi-step synthesis of API precursors before final salt formation and crystallization stages.

Final product types

• Central nervous system (CNS) APIs such as selective receptor antagonists, cognition-enhancing drug candidates, or proprietary investigational new drugs (INDs).

2. Custom Peptide Synthesis for Drug Discovery Services

CDMOs and peptide custom synthesis laboratories incorporate this protected diamine during the segment coupling steps of complex backbone-modified peptides, harnessing its rigid conformation to induce desired secondary structure. Its involvement requires careful Boc deprotection cycles under controlled acidity, supporting scale-up batch reproducibility and quality batch records for synthetic peptides entering clinical research.

Industry compliance standards

• PIC/S GMP part II (for investigational and preclinical batches)
• US FDA 21 CFR Part 210/211
• European Pharmacopoeia (Ph. Eur.) requirements for synthetic peptides
• ISO 9001:2015 (Quality Management for Laboratory Processes)

Typical usage ratio

• 1–8 mol% in selected peptide segment coupling; determined by requisite cyclic constraint and application-specific sequence modification.

Downstream process integration

• Employed at protected amino acid coupling stage, then subject to selective Boc removal and further chain extension on solid-phase or in solution, followed by final purification (RP-HPLC) and lyophilization.

Final product types

• Peptidic drug candidates, bioactive conformationally-locked analogs, peptide library screening sets, pharmacological tool compounds.

3. Synthesis of Agrochemical Intermediates for Crop Protection Agents

Crop protection manufacturers employ this compound as a structural core during scaffold assembly for next-generation insecticide and herbicide candidates, leveraging its bicyclic framework in intermediate construction where stability of the Boc group ensures selectivity in stepwise functionalization. Production lines focus on minimizing byproduct formation and validating intermediate purity before downstream coupling reactions.

Industry compliance standards

• FAO/WHO Guidelines on Good Manufacturing Practice for Pesticides
• European REACH regulation (EC 1907/2006)
• ISO 9001:2015 (Production Quality Control)
• Chemical Industry Safety Data Sheet (GB/T 16483-2008, China)

Typical usage ratio

• 2–7 mol% in targeted heterocycle intermediate synthesis; finely tuned based on downstream crop protection agent scaffold fusion pathway.

Downstream process integration

• Fed directly at skeleton assembly phase in multi-step syntheses before further alkylation, acylation, or cyclization required to achieve ultimate agrochemical activity.

Final product types

• Insecticide active ingredient intermediates, herbicide candidate scaffolds, pre-commercial agricultural chemical samples for regulatory studies.

4. Synthesis of Advanced Functional Polymers for Electronics

Specialty polymer manufacturers use this protected diamine derivative as a monomeric input during the tailored synthesis of rigid-rod polymers for antistatic coatings, OLED component insulators, and precision dielectric films. The constrained structure imparts targeted glass transition behaviors and enhances insulating characteristics. Downstream processing rigorously controls Boc deprotection to prevent chain-end defects during polymerization and to qualify batch properties for demanding electronic applications.

Industry compliance standards

• IEC 60695 (Electrical Insulating Materials Tests)
• RoHS 2011/65/EU for electronics chemicals
• ISO 9001:2015 (Quality Management in Advanced Materials)
• UL 94 Flammability Standard (for downstream components)

Typical usage ratio

• 3–10 wt% relative to total monomer content; tailored to target film thickness and dielectric property requirements for the intended electronic function.

Downstream process integration

• Integrated as a diamine monomer at initial polymerization feed, then subjected to controlled Boc group cleavage; processed through solution or melt polymerization followed by casting or molding.

Final product types

• Antistatic films, dielectric insulation layers in OLED displays, specialty high-frequency PCB laminates, precision polymer dielectrics.